A single dose of psilocybin reduces depression symptoms
A large clinical trial has found that a single 25mg dose of COMP360 psilocybin had a significant impact on depression symptoms in participants with...
Researchers begin development of new endometrial cancer treatment
An international research team has identified a new therapeutic strategy to combat endometrial cancer and has begun developing a new treatment.
The new therapy is...
A large-scale study of common blood thinners identifies the safest option
A large-scale comparison of blood thinners by researchers from University College London has identified the drugs with the lowest risk of gastrointestinal bleeding.
The researchers...
Dentists prescribed excessive antibiotics for toothache in pandemic
A new report from the University of Manchester highlights that dentists were forced to prescribe unnecessary antibiotics for toothache during the pandemic.
In the UK,...
Experimental liver cancer treatment provides new care options
A new drug, discovered by the University of Barcelona, that can inhibit cell division and growth in enzymes could revolutionise liver cancer treatment.
The new...
Access to antibiotics without a prescription is damaging healthcare
Research from the University of Gothenburg has suggested many people in Sweden are obtaining antibiotics without a prescription, causing serious issues for the Swedish...
The controversy around falsified Alzheimer’s research
NervGen Pharma Corp. explores approaches to Alzheimer’s treatment culminating in its own novel method for treating nervous system damage using the revolutionary NVG-291 drug.
Finding...
Ground-breaking Hepatitis C virus imaging could lead to vaccine
A team of researchers from Scripps Research and the University of Amsterdam have learned how to map high-resolution images of critical proteins on the...
Blood pressure medication is equally effective at any time of day
A new study by the University of Edinburgh finds that blood pressure medications are effective regardless of whether it’s administered in the morning or...
Experimental medicines could be the key to a HIV cure
A team of Danish researchers have made significant steps towards finding a HIV cure through the use of experimental medicines.
Existing treatment for HIV can...
Making pharma supply chains more sustainable
Nico Ros, Co-Founder and CTO of SkyCell discusses how to make pharma supply chains more sustainable.
As businesses everywhere look for ways to reduce their...
New malaria vaccination could be deployed by 2023
A new malaria vaccination, developed by the University of Oxford, could be launched in 2023 after trials find it to be 80% effective.
The new...
Dementia diagnosis is more likely in people taking multiple medications
A dementia diagnosis is more likely in people who are taking three or more medications, according to an international research team.
The study is the...
New cancer treatments made possible by genome research
Researchers from the University of Bern have outlined new cancer treatments against non-small cell lung cancer by analysing the ‘dark matter’ of the human...
Making treatment for malignant tumours better for the kidneys
Researchers at the Paul Scherrer Institute have optimised treatment for malignant tumours using radionuclides. Potential side effects to the kidneys can now be significantly...
Exciting trial offers new hope for Crohn’s disease patients
A new clinical trial beginning in Scotland will aim to improve treatment options for patients with Crohn’s disease.
Crohn’s disease is a lifelong condition causing...
Diagnostics and antimicrobial therapy
Lorna Rothery spoke to Professor Till Bachmann, an expert in molecular diagnostics and Chair of the JPIAMR’s SAB, about how diagnostics can inform optimal...
No difference between spinal or general anaesthesia in hip fracture surgery
A new study from the University of Bristol has found no differences in the safety or effectiveness of spinal or general anaesthesia for hip...
Europe’s quest for new antibiotics
Rosa Castro of the European Public Health Alliance argues for an alternative to a transferable exclusivity extension to address the lack of new antibiotics.
At...
New melanoma treatment reduces the risk of reoccurrence
Around 1,500 people aged 12 years and over will benefit from a new melanoma treatment that reduces the risk of reoccurrence and spreading.
Melanoma is...
